Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
m 03:43 | Cytarabine (Ara-C) diffhist +156 Jwarner talk contribs →History of changes in PMDA indication |
28 May 2024
m 23:12 | Allogeneic HSCT diffhist +605 Jwarner talk contribs →References |
m 20:24 | Graft versus host disease diffhist +1,033 Jwarner talk contribs →Methotrexate & Tacrolimus |
|
10:34 | Myelodysplastic syndrome 2 changes history +1,432 [Jwarner (2×)] | |||
m |
|
10:34 (cur | prev) -212 Jwarner talk contribs | |||
|
10:34 (cur | prev) +1,644 Jwarner talk contribs →Erythropoietin alfa monotherapy {{#subobject:9uyac1|Regimen=1}} |
27 May 2024
m 23:46 | Graft versus host disease diffhist +940 Jwarner talk contribs →Methotrexate & Tacrolimus |
26 May 2024
m 12:55 | Rituximab (Rituxan) diffhist -13 Jwarner talk contribs →Also known as |